Crossmark

Antioxidant Therapy in a Patient with Hyperprolinemia Type 1 Presenting with Mild Neuromotor Retardation and Speech Disturbance

Published Online: 2021-03-27

Published Print: 2021-06

Authors

Ersoy, Melike

Yılmaz, Semra

Ceylaner, Serdar
License Information

Text and Data Mining valid from 2021-03-27

Version of Record valid from 2021-03-27
More Information

Article History

Received: 1 January 2021

Accepted: 16 March 2021

First Online: 27 March 2021

Declarations

:

: None.

Free to read: This content has been made available to all.

Document is current